Literature DB >> 11092613

Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas.

K Warzocha1, P Ribeiro, N Renard, J Bienvenu, C Charlot, B Coiffier, G Salles.   

Abstract

Excessive production of the tumor necrosis factor (TNF) ligand-receptor system has been found to contribute to the severity of non-Hodgkin's lymphoma (NHL). We therefore investigated the expression of TNF, lymphotoxin alpha (LTalpha), lymphotoxin beta (LTbeta), and their receptor (p55, p75, LTbeta-R) transcripts within the tumor tissue in different NHL histological subtypes. The constitutive expression of genes coding for TNF-related ligands and receptors was found in almost all 31 NHL samples studied. Semi-quantitative reverse transcription/polymerase chain reaction and computed densitometry assays revealed that the amounts of TNF, LTalpha, p55, and LTbeta-R mRNA were higher in follicular NHL than in other histological entities. Therefore tumor cell immunopurification was performed in representative follicular NHL samples and consistent results were obtained. The pattern of LTbeta gene expression was different from that of the other molecules, indicating the existence of distinct mechanisms of gene regulation. These results indicate that the transcription of genes coding for the TNF ligand-receptor system in NHL tumor tissue is more widespread than originally thought and that the heterogeneity of their expressions might be related to histological features. The expression of TNF-related ligands and receptors in tumor tissues is likely to contribute to the clinicopathological features of lymphoid-derived malignancies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092613     DOI: 10.1007/s002620000127

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  5 in total

1.  Increased expression of tumor necrosis factor-α is associated with advanced colorectal cancer stages.

Authors:  Omar A Al Obeed; Khayal A Alkhayal; Abdulmalik Al Sheikh; Ahmad M Zubaidi; Mansoor-Ali Vaali-Mohammed; Robin Boushey; James H Mckerrow; Maha-Hamadien Abdulla
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

2.  Tumor necrosis factor-α is associated with positive lymph node status in patients with recurrence of colorectal cancer-indications for anti-TNF-α agents in cancer treatment.

Authors:  M Grimm; M Lazariotou; S Kircher; A Höfelmayr; C T Germer; B H A von Rahden; A M Waaga-Gasser; M Gasser
Journal:  Cell Oncol (Dordr)       Date:  2011-08       Impact factor: 6.730

3.  Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.

Authors:  C Pangault; P Amé-Thomas; P Ruminy; D Rossille; G Caron; M Baia; J De Vos; M Roussel; C Monvoisin; T Lamy; H Tilly; P Gaulard; K Tarte; T Fest
Journal:  Leukemia       Date:  2010-10-14       Impact factor: 11.528

4.  Circulating Tfh1 (cTfh1) cell numbers and PD1 expression are elevated in low-grade B-cell non-Hodgkin's lymphoma and cTfh gene expression is perturbed in marginal zone lymphoma.

Authors:  Elliot T Byford; Matthew Carr; Eleni Ladikou; Matthew J Ahearne; Simon D Wagner
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

5.  Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas.

Authors:  Rita Lh Yim; Kwan Yeung Wong; Yok Lam Kwong; Florence Loong; Chung Ying Leung; Raymond Chu; William Wai Lung Lam; Pak Kwan Hui; Raymond Lai; Chor Sang Chim
Journal:  Oncotarget       Date:  2014-10-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.